Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

STAAR Surgical Company - Common Stock (NQ:STAA)

25.85 -1.55 (-5.66%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 12, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,038,436
Open 27.40
Bid (Size) 25.81 (500)
Ask (Size) 25.84 (2,100)
Prev. Close 27.40
Today's Range 25.25 - 27.40
52wk Range 13.50 - 30.88
Shares Outstanding 48,333,250
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Broadwood Partners Calls for the Appointment of New Directors at STAAR Surgical to Oversee Go-Shop Process
From Broadwood Partners, L.P.
Via Business Wire
3 Small-Cap Stocks That Fall Short
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside... 
Via StockStory

Performance

YTD
+7.3%
+7.3%
1 Month
-5.1%
-5.1%
3 Month
-5.6%
-5.6%
6 Month
+36.1%
+36.1%
1 Year
-15.0%
-15.0%

More News

Read More
STAAR Surgical Announces Amendments to Alcon Merger Agreement
From STAAR Surgical Company
Via Business Wire
Yunqi Capital Applauds STAAR Surgical’s Strong Third Quarter Results and Reiterates That the Proposed Sale to Alcon Should Be Terminated
From Yunqi Capital Limited
Via Business Wire
Staar Surgical Shares Slip After Alcon Refuses To Reconsider Merger Consideration
Via Stocktwits
STAAR Surgical Stock Rises After Adjournment Of Stockholders’ Meeting To Discuss Proposed Merger With Alcon
Via Stocktwits
2 High-Flying Stocks on Our Buy List and 1 We Find Risky
Via StockStory
STAAR Surgical Reports Third Quarter 2025 Results
From STAAR Surgical Company
Via Business Wire
3 Stocks Under $50 We Keep Off Our Radar
Via StockStory
Broadwood Partners Condemns Alcon’s Fallacious Attacks on STAAR Surgical and Its Prospects
From Broadwood Partners, L.P.
Via Business Wire
Yunqi Capital Issues Letter to STAAR Surgical Board Calling for Termination of the Proposed Merger with Alcon
From Yunqi Capital Limited
Via Business Wire
1 Cash-Burning Stock for Long-Term Investors and 2 We Turn Down
Via StockStory
Topics Bankruptcy
1 Cash-Heavy Stock on Our Buy List and 2 Facing Challenges
Via StockStory
STAAR Surgical Sets New Record Date and Postpones STAAR Special Meeting of Stockholders in Light of Ongoing Discussions with Alcon
From STAAR Surgical Company
Via Business Wire
Yunqi Capital Issues Letter to STAAR Surgical Board Opposing Adjournment of the Special Meeting and Calling for the Company to Move Beyond the Proposed Merger with Alcon
From Yunqi Capital Limited
Via Business Wire
Broadwood Partners Condemns Decision by STAAR Surgical and Alcon to Delay Final Vote on Proposed Transaction
From Broadwood Partners, L.P.
Via Business Wire
Alcon and STAAR Surgical Announce Adjournment of STAAR Special Meeting of Stockholders
From STAAR Surgical Company
Via Business Wire
Broadwood Partners Intends to Call Special Meeting to Remove Several STAAR Surgical Directors
From Broadwood Partners, L.P.
Via Business Wire
Yunqi Capital Issues Letter to STAAR Surgical’s Board Calling for Timely Convening of the Special Meeting to Vote on the Alcon Transaction
From Yunqi Capital Limited
Via Business Wire
Broadwood Partners Highlights Growing Opposition to STAAR Surgical’s Proposed Sale to Alcon
From Broadwood Partners, L.P.
Via Business Wire
STAAR Surgical Announces Preliminary Net Sales Results for Third Quarter 2025
From STAAR Surgical Company
Via Business Wire
3 Unprofitable Stocks We Approach with Caution
Via StockStory
Broadwood Partners Issues Letter to STAAR Surgical’s Board Urging it to Allow Timely Shareholder Vote on Alcon Sale
From Broadwood Partners, L.P.
Via Business Wire
STAAR Surgical Affirms that No Acquisition Proposals Have Been Received From Any Party Other Than Alcon
From STAAR Surgical Company
Via Business Wire
Broadwood Partners: All Three Leading Proxy Advisory Firms Recommend STAAR Surgical Shareholders Vote “AGAINST” Sale to Alcon
From Broadwood Partners, L.P.
Via Business Wire

Frequently Asked Questions

Is STAAR Surgical Company - Common Stock publicly traded?
Yes, STAAR Surgical Company - Common Stock is publicly traded.
What exchange does STAAR Surgical Company - Common Stock trade on?
STAAR Surgical Company - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for STAAR Surgical Company - Common Stock?
The ticker symbol for STAAR Surgical Company - Common Stock is STAA on the Nasdaq Stock Market
What is the current price of STAAR Surgical Company - Common Stock?
The current price of STAAR Surgical Company - Common Stock is 25.85
When was STAAR Surgical Company - Common Stock last traded?
The last trade of STAAR Surgical Company - Common Stock was at 11/12/25 04:00 PM ET
What is the market capitalization of STAAR Surgical Company - Common Stock?
The market capitalization of STAAR Surgical Company - Common Stock is 1.25B
How many shares of STAAR Surgical Company - Common Stock are outstanding?
STAAR Surgical Company - Common Stock has 1B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.